НовостиBenzingaB of A Securities Initiates Coverage On Iambic Therapeutics with Buy Rating, Announces Price Target of $30 B of A Securities Initiates Coverage On Iambic Therapeutics with Buy Rating, Announces Price Target of $30 Benzinga 2026.11.09 11:56 (GMT+0) Открыть на Benzinga Другие новости